Viewing data from:

BALSALAZIDE DISODIUM

ANDA

BALSALAZIDE DISODIUM | A077806 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: COLAZAL(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Balsalazide Disodium (2023)

Total Spending

$23.5M

Total Claims

108,685

Beneficiaries

24,237

Avg Cost/Unit

$0.60

Spending Trend

$24.0M(2019)→$27.0M(2020)→$25.7M(2021)→$24.8M(2022)→$23.5M(2023)

YoY Change:-1.0%

5yr CAGR:-0.8%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs7 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

PHARMAZELL GMBHBALSALAZIDE DISODIUM

DMF 164252003

FORMOSA LABORATORIES INCBALSALAZIDE DISODIUM DIHYDRATE USP

DMF 173262004

SIGNA SA DE CVBALSALAZIDE DISODIUM DIHYDRATE USP

DMF 188942005

SA AJINOMOTO OMNICHEM NVInactiveBALSALAZIDE DISODIUM

DMF 122871996

COURTAULDS CHEMICALSInactiveBALSALAZIDE DISODIUM

DMF 122891996

SA AJINOMOTO OMNICHEM NVInactiveBALSALAZIDE DISODIUM

DMF 162562003

FARCHEMIA SRLInactiveBALSALAZIDE DISODIUM DIHYDRATE

DMF 175002004

IPCA LABORATORIES LTDInactiveBALSALAZIDE DISODIUM DIHYDRATE

DMF 177802004

CHIFENG ARKER PHARMACEUTICAL TECHNOLOGY CO LTDInactiveBALSALAZIDE DISODIUM DIHYDRATE

DMF 185732005

OLON SPAInactiveBALSALAZIDE DISODIUM SALT

DMF 196842006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 750MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Dec 28, 2007

No patent or exclusivity listings for this strength.